Beam Therapeutics Inc

NASDAQ:BEAM   1:26:33 PM EDT
90.21
+1.69 (+1.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Beam Therapeutics, Inc. Stock, NASDAQ:BEAM

26 Landsdowne Street, 2nd floor, Cambridge, Massachusetts 02139
United States of America
Phone: +1.857.327.8775
Number of Employees: 118

Description

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. The company was founded by David R. Liu, Feng Zhang and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.